Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 4/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 9/20 | 0.37 |
| ▸ | CCR1 | P32246 | 1/20 | 0.37 |
| ▸ | CCR8 | P51685 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | ERG | P11308 | 1/20 | 0.35 |
| ▸ | TACR3 | P29371 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22126371 | 0.87 | MEN1 (0.47) | ALDH1A1 | |
| SCHEMBL30709317 | 0.86 | TGFBR1 (0.37) | TGFBR1CYP2A6IRAK4CCR1CCR8 | |
| SCHEMBL30709303 | 0.84 | TGFBR1 (0.39) | TGFBR1CYP2A6IRAK4GRM5ERG | |
| SCHEMBL13203076 | 0.84 | CYP19A1 (0.37) | ALDH1A1 | |
| SCHEMBL30709493 | 0.84 | IRAK4 (0.40) | CYP2A6IRAK4CCR1CCR8GRM5 | |
| SCHEMBL16189109 | 0.82 | ALDH1A1 (0.39) | TGFBR1IRAK4ERGTACR3KCNH2 | |
| SCHEMBL30709453 | 0.82 | MEN1 (0.46) | ALDH1A1 | |
| SCHEMBL19928003 | 0.81 | MEN1 (0.40) | ALDH1A1 | |
| SCHEMBL30709518 | 0.80 | MEN1 (0.37) | ALDH1A1 | |
| SCHEMBL20771508 | 0.80 | CYP19A1 (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | TGFBR1 3403/4885CYP2A6 536/4885IRAK4 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.